Intra-Cellular Therapies, Inc.

210 articles about Intra-Cellular Therapies, Inc.

• Intra-Cellular Therapies, Inc. Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia

  7/29/2010

• Intra-Cellular Therapies, Inc. Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

  3/10/2009

• Intra-Cellular Therapies, Inc. Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

  1/13/2009

• Intra-Cellular Therapies, Inc. Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722

  4/9/2008

• Intra-Cellular Therapies, Inc. Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs

  2/15/2008

• Intra-Cellular Therapies, Inc. Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia

  12/20/2007

• Intra-Cellular Therapies, Inc. Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs

  12/19/2007

• Intra-Cellular Therapies, Inc. Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction

  9/18/2007

• Intra-Cellular Therapies, Inc. Initiates Phase I Clinical Program for Schizophrenia and Sleep Maintenance Disorders

  6/21/2007

• Shamrock Structures To Provide Proteomics Services For Biopharmaceutical Company

  8/5/2004